Cytori Cell Research Institute, Inc. (3750.T)
JPY 916.0
(-1.51%)
JPY 916.0
(-1.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.56 Billion | 2.14 Billion | 1.33 Billion | 1.38 Billion | 1.18 Billion |
| Cost of Revenue | 267.77 Million | 875.72 Million | 476.34 Million | 627.96 Million | 424 Million |
| Gross Profit | 1.29 Billion | 1.26 Billion | 859.23 Million | 760.32 Million | 756 Million |
| Operating Expenses | 1.85 Billion | 2.06 Billion | 1.32 Billion | 1.49 Billion | 393 Million |
| Selling, General and Administrative Expenses | 1.5 Billion | 1.78 Billion | 1.08 Billion | 1.26 Billion | 155.24 Million |
| Research and Development Expenses | 351.35 Million | 145.23 Million | 32 Million | - | - |
| Other Expenses | 207 Million | 73 Million | 156.68 Million | 84.59 Million | - |
| Cost and Expenses | 2.33 Billion | 2.93 Billion | 1.79 Billion | 2.11 Billion | 817 Million |
| Operating Income | -772.74 Million | -794.35 Million | -462.32 Million | -731.67 Million | -129 Million |
| Interest Expense | 153.81 Million | 129.24 Million | 93.19 Million | 84.53 Million | 57.47 Million |
| Income Tax Expense | -1.15 Billion | -106.34 Million | 11.75 Million | 121.2 Million | 1 Million |
| Earnings before Tax | -1.01 Billion | -1.16 Billion | -65.33 Million | -654.24 Million | 319 Million |
| Net Income | 138.15 Million | -1.05 Billion | -77.63 Million | -831.86 Million | 319 Million |
| Earnings Per Share Basic | 15.47 | -118.71 | -8.79 | -101.64 | 47.52 |
| Earnings Per Share Diluted | 15.42 | -118.71 | -8.79 | -101.64 | 47.52 |
| Weighted Average Shares Outstanding | 8.92 Million | 8.92 Million | 8.82 Million | 8.18 Million | 6.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.95 Million | 8.92 Million | 8.82 Million | 8.18 Million | 6.71 Million |
| Gross Margin | 0.83 | 0.59 | 0.64 | 0.55 | 0.64 |
| EBIT Margin | -0.39 | -0.18 | 0.01 | -0.24 | 0.04 |
| Profit Margin | 0.09 | -0.49 | -0.06 | -0.60 | 0.27 |
| EBITDA | -603.09 Million | -705.34 Million | 348.9 Million | -261.85 Million | 43 Million |
| Earnings Before Tax Margin | -0.50 | -0.37 | -0.35 | -0.53 | -0.11 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 39 Million | 1.56 Billion | 148.79 Million | 549.05 Million | 390.05 Million | 472.47 Million |
| Cost of Revenue | 19 Million | 267.77 Million | 12.15 Million | 121.19 Million | 63.04 Million | 71.38 Million |
| Gross Profit | 20 Million | 1.29 Billion | 136.64 Million | 427.86 Million | 327.01 Million | 401.09 Million |
| Operating Expenses | 259 Million | 2.06 Billion | 414.75 Million | 568.42 Million | 543.95 Million | 538.22 Million |
| Selling, General and Administrative Expenses | 259 Million | - | 144 Million | 672 Million | 440 Million | 538 Million |
| Research and Development Expenses | - | - | 351 Million | 100 Million | 71 Million | 105 Million |
| Other Expenses | - | -472.78 Million | -503.78 Million | 19.7 Million | 991 Thousand | 10.29 Million |
| Cost and Expenses | 278 Million | 2.33 Billion | 426.9 Million | 689.61 Million | 606.99 Million | 609.6 Million |
| Operating Income | -239 Million | -772.74 Million | -278.11 Million | -140.56 Million | -216.94 Million | -137.13 Million |
| Interest Expense | 18.4 Million | 153.81 Million | 35.19 Million | 39.31 Million | 40.48 Million | 38.83 Million |
| Income Tax Expense | 382 Thousand | -1.15 Billion | -1.16 Billion | -4.24 Million | 28.32 Million | -4.67 Million |
| Earnings before Tax | -242 Million | -1.01 Billion | -478.51 Million | -113.42 Million | -253.34 Million | -165.93 Million |
| Net Income | -242 Million | 138.15 Million | 690.79 Million | -109.3 Million | -282.04 Million | -161.29 Million |
| Earnings Per Share Basic | -27.10 | - | 77.28 | -12.24 | -31.59 | -18.06 |
| Earnings Per Share Diluted | -27.10 | - | 76.26 | -12.24 | -31.59 | -18.06 |
| Weighted Average Shares Outstanding | 8.92 Million | 8.94 Million | 9.04 Million | 8.92 Million | 8.92 Million | 8.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.92 Million | 8.95 Million | 9.05 Million | 8.92 Million | 8.92 Million | 8.92 Million |
| Gross Margin | 0.51 | 0.83 | 0.92 | 0.78 | 0.84 | 0.85 |
| EBIT Margin | -4.51 | - | -5.25 | -0.22 | -0.55 | -0.27 |
| Profit Margin | -6.21 | 0.09 | 4.64 | -0.20 | -0.72 | -0.34 |
| EBITDA | -175.75 Million | - | -781.89 Million | -120.85 Million | -215.95 Million | -126.83 Million |
| Earnings Before Tax Margin | -6.13 | -0.50 | -1.87 | -0.26 | -0.56 | -0.29 |
STRA
NSANY
688367
3883
ESSITY-B
2300